Quetmolimab: A Deep Dive into KANAb 001 and E-6011 The compound, quetmolimab, represents a promising approach aimed at programmed cell death protein 1. Early clinical results from the two initiatives, KANAb 001 and https://www.targetmol.com/compound/quetmolimab